Joel Greenblatt's ARWR Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 56,273 shares of Arrowhead Pharmaceuticals, Inc. (ARWR) worth $3.74 M, representing 0.01% of the portfolio. First purchased in 2019-Q1, this long-term strategic position has been held for 22 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in ARWR, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2019, adding 176,317 shares. Largest reduction occurred in Q4 2019, reducing 129,837 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Arrowhead Pharmaceuticals (ARWR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Arrowhead Pharmaceuticals (ARWR) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +24,410 | Add 76.61% | 56,273 | $66.39 |
| Q3 2025 | +13,000 | Add 68.92% | 31,863 | $34.49 |
| Q2 2025 | +18,863 | New Buy | 18,863 | $15.80 |
| Q3 2023 | -5,993 | Sold Out | 0 | $0.00 |
| Q2 2023 | +5,993 | New Buy | 5,993 | $35.66 |
| Q1 2023 | -13,890 | Sold Out | 0 | $0.00 |
| Q4 2022 | -10,706 | Reduce 43.53% | 13,890 | $40.56 |
| Q3 2022 | -91 | Reduce 0.37% | 24,596 | $33.05 |
| Q2 2022 | +12,365 | Add 100.35% | 24,687 | $35.20 |
| Q1 2022 | -89 | Reduce 0.72% | 12,322 | $46.02 |
| Q3 2021 | -15 | Reduce 0.12% | 12,411 | $62.44 |
| Q1 2021 | -5,489 | Reduce 30.64% | 12,426 | $66.31 |
| Q4 2020 | -12,402 | Reduce 40.91% | 17,915 | $76.75 |
| Q3 2020 | -31,580 | Reduce 51.02% | 30,317 | $43.05 |
| Q2 2020 | -45,627 | Reduce 42.43% | 61,897 | $43.18 |
| Q1 2020 | -30,987 | Reduce 22.37% | 107,524 | $28.77 |
| Q4 2019 | -129,837 | Reduce 48.38% | 138,511 | $63.43 |
| Q3 2019 | +176,317 | Add 191.58% | 268,348 | $28.18 |
| Q2 2019 | +54,728 | Add 146.71% | 92,031 | $26.50 |
| Q1 2019 | +37,303 | New Buy | 37,303 | $18.36 |
Joel Greenblatt's Arrowhead Pharmaceuticals Investment FAQs
Joel Greenblatt first purchased Arrowhead Pharmaceuticals, Inc. (ARWR) in Q1 2019, acquiring 37,303 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Arrowhead Pharmaceuticals, Inc. (ARWR) for 22 quarters since Q1 2019.
Joel Greenblatt's largest addition to Arrowhead Pharmaceuticals, Inc. (ARWR) was in Q3 2019, adding 268,348 shares worth $7.56 M.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 56,273 shares of Arrowhead Pharmaceuticals, Inc. (ARWR), valued at approximately $3.74 M.
As of the Q4 2025 filing, Arrowhead Pharmaceuticals, Inc. (ARWR) represents approximately 0.01% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Arrowhead Pharmaceuticals, Inc. (ARWR) was 268,348 shares, as reported at the end of Q3 2019.